Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022

SELL
$107.43 - $135.93 $3.61 Million - $4.57 Million
-33,624 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $1.33 Million - $1.51 Million
12,520 Added 59.33%
33,624 $3.66 Million
Q2 2021

Aug 16, 2021

BUY
$105.21 - $117.21 $79,328 - $88,376
754 Added 3.71%
21,104 $2.38 Million
Q1 2021

May 17, 2021

BUY
$102.3 - $112.62 $839,780 - $924,497
8,209 Added 67.61%
20,350 $2.2 Million
Q4 2020

Feb 16, 2021

SELL
$80.49 - $108.67 $224,969 - $303,732
-2,795 Reduced 18.71%
12,141 $1.3 Million
Q3 2020

Nov 16, 2020

SELL
$85.91 - $100.83 $1.69 Million - $1.98 Million
-19,626 Reduced 56.78%
14,936 $1.26 Million
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $902,230 - $1.21 Million
12,297 Added 55.23%
34,562 $3.39 Million
Q1 2020

May 15, 2020

BUY
$64.5 - $97.79 $810,507 - $1.23 Million
12,566 Added 129.56%
22,265 $1.7 Million
Q4 2019

Feb 14, 2020

BUY
$72.13 - $90.25 $193,669 - $242,321
2,685 Added 38.28%
9,699 $859,000
Q3 2019

Nov 14, 2019

SELL
$62.98 - $75.72 $693,031 - $833,222
-11,004 Reduced 61.07%
7,014 $531,000
Q2 2019

Aug 14, 2019

BUY
$65.7 - $83.98 $669,417 - $855,672
10,189 Added 130.14%
18,018 $1.31 Million
Q1 2019

May 15, 2019

BUY
$77.14 - $90.79 $603,929 - $710,794
7,829 New
7,829 $631,000
Q4 2018

Feb 14, 2019

SELL
$77.85 - $96.01 $1.35 Million - $1.66 Million
-17,317 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$88.91 - $98.84 $1.54 Million - $1.71 Million
17,317 New
17,317 $1.64 Million
Q2 2018

Aug 14, 2018

SELL
$89.78 - $106.23 $395,480 - $467,943
-4,405 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$92.01 - $123.21 $405,304 - $542,740
4,405 New
4,405 $417,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $349B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Capital Markets Trading Uk LLP Portfolio

Follow Capital Markets Trading Uk LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Markets Trading Uk LLP, based on Form 13F filings with the SEC.

News

Stay updated on Capital Markets Trading Uk LLP with notifications on news.